Deals & Capital Markets
Royalty Pharma Bets $500M on Teva's Vitiligo Antibody, Targeting Market With Only One Approved Drug
3d ago
You're signed outSign in or to get full access.
TEVA PHARMACEUTICAL INDUSTRIES (TEVA) Earnings Call Transcripts
Browse quarterly earnings call transcripts for TEVA PHARMACEUTICAL INDUSTRIES.
Q3 2025
Nov 5, 2025
Q2 2025
Jul 30, 2025
Q1 2025
May 7, 2025
Q4 2024
Jan 29, 2025
Q4 2020
Feb 10, 2021
Q3 2020
Nov 5, 2020
Q2 2020
Aug 5, 2020
Q1 2020
May 7, 2020